The Disease Severity In Patients With Psoriasis
- Conditions
- Psoriasis
- Registration Number
- NCT05943405
- Lead Sponsor
- Universitas Sebelas Maret
- Brief Summary
This observational study aims to evaluate new markers to predict disease activity in psoriasis. The main question is SGOT, SGPT, GGT, hs-CRP, and apo B related to disease severity in psoriasis.
- Detailed Description
Psoriasis patients who had signed an informed consent were assessed for PASI scores and 5 cc of blood was drawn for GGT, hs-CRP, and apo B examinations. A PASI score is a tool used to measure the severity and extent of psoriasis. PASI is an acronym for Psoriasis Area and Severity Index.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 33
- Clinical diagnosis of Psoriasis
- Heart Failure
- Diabetes Mellitus
- Kidney Disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gamma-Glutamyl Transferase only in admission Gamma-Glutamyl Transferase was check in admission, reference range for adults is 5 to 40 U/L (units per liter)
Apolipoprotein B only in admission Apolipoprotein B (ApoB) is the primary apolipoprotein and is the carrier for the following lipids: chylomicrons, low-density lipoprotein ( LDL), very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein. Unit used in mg/dL
High-sensitivity c-reactive protein only in admission High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation that predicts incident myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death. Unit used in mg/L
PASI only in admission A PASI (The Psoriasis Area and Severity Index) score can range from 0 to 72
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Universitas Sebelas Maret Hospital
🇮🇩Sukoharjo, Central Java, Indonesia